Detalhe da pesquisa
1.
Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity.
Molecules
; 22(3)2017 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28282886
2.
SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti-Trypanosoma brucei Agent.
ACS Med Chem Lett
; 10(4): 528-533, 2019 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30996791
3.
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform.
SLAS Discov
; 24(3): 346-361, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30784368
4.
Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring.
Front Hum Neurosci
; 12: 226, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29915533
5.
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery.
ACS Omega
; 2(9): 5666-5683, 2017 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28983525
6.
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs.
J Med Chem
; 59(16): 7598-616, 2016 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27411733